You Searched For "biopharmaceutical" and got 20 results
Sort By:
3 mins read
Biopharmaceutical mergers and acquisitions surge to new highs
The biopharmaceutical industry experiences a surge in mergers and acquisitions, with GlobalData rep…
2 mins read
The first eye drops that sharpen close-up vision could replace reading glasses for millions of adults
Vuity, a new eye drop from AbbVie company Allergan, can improve near vision for up to six hours aft…
Andrea Michelson
1 min read
Another Chinese Covid-19 vaccine enters late-stage human trials with a plan to produce 300 million doses annually
Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. has commenced the phase-3 cl…
4 mins read
In the competitive world of pharma, companies need to focus on worker well-being to retain top talent, says Ferring's HR exec
Purvi Tailor, Ferring Pharmaceuticals' VP of HR, says focusing holistically on worker well-being is…
Julia Hood
4 mins read
India's bioeconomy reaches valuation of $151 billion, contributes 4.25% to GDP: Report
It was released during a session at the Global Bio-India Summit 2024. The report said that…
PTI
3 mins read
China's city dwellers will soon have more pets than toddlers, and there's 1 way investors can cash in on the trend, Goldman Sachs says
China will have more than 70 million urban pets and less than 40 million children under the age of …
Kwan Wei Kevin Tan,Aditi Bhar…
1 min read
Indegene shares rally over 26% in debut trade
On the NSE, it started the trade at Rs 655, registering a gain of 44.91 per cent. The stock end…
PTI
1 min read
Indegene IPO subscribed 1.67 times on Day 1 of offer
The category for non institutional investors received 4.13 times subscription, while the portion fo…
PTI
2 mins read
Indegene's ₹1,842 crore IPO to open on May 6
The company's IPO comprises a fresh issue of equity shares worth up to Rs 760 crore and an Offe…
PTI
2 mins read
Indegene IPO allotment – How to check allotment, GMP, listing date and more
Bengaluru-based Indegene Limited, which provides services to biopharmaceutical, emerging biotech an…
1 min read
A new Ozempic rival helps patients lose fat, but keep their muscle the holy grail for a weight-loss drug
The Ozempic rival helped people lose weight while keeping more of their muscles intact. In a trial,…
Hilary Brueck
1 min read
A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year
The Tema Cardiovascular and Metabolic ETF holds positions in around 20 companies, including Novo No…
Jennifer Sor
2 mins read
Concord Biotech lists at 21% premium, beats grey market expectations
Ahmedabad-based pharma company Concord Biotech made its D-street debut at a 21% premium on Friday, …
1 min read
Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says
The anti-obesity market is "still in its early stages" but could become a $100 billion industry by …
George Glover
7 mins read
America's crisis of meaningless work
It's not the pay or the perks causing American workers to disengage. It's the lack of purpose.
Molly Lipson
3 mins read
Concord Biotech’s IPO subscribed almost 25x with good interest from QIBs
Ahmedabad-based pharma company Concord Biotech received a tepid response from investors on the firs…
5 mins read
India’s deal making stayed cautious in 2023, declined by over half to $66 bn
The stock market may have hit new highs in 2023, but deal making activity continued to battle the l…
2 mins read
A Hollywood director took millions of dollars in Netflix funding and used it to trade options and crypto, report says. Here's a closer look at how he used the cash.
"47 Ronin" director Carl Erik Rinsch reportedly used production funds from Netflix to place bets on…
Theron Mohamed
1 min read
Concord Biotech IPO to open on August 4; price band at ₹705-741/ share
Rare Enterprises-backed Concord Biotech on Monday said it has fixed a price band of Rs 705-741 a sh…
PTI
1 min read
Bristol Myers Squibb to invest ₹800 crore to set up drug development, IT facility in Hyderabad
Bristol Myers Squibb, a world's leading biopharmaceutical company will establish a state of-the-art…